Award Data

The overall objective of this proposal is to demonstrate that AMG Engineering, a proven SDOVSB, has the wherewith all to design, plan, and implement processes that meet DLA’s criteria for achieving their supplier development efforts regarding the production of Legacy products with reduced lead time and costs. Phase I research will show the feasibility of manufacturing Part Number K405006, 3-Way ...

THIS PROJECT WILL DEVELOP TWO INTER-RELATED HEALTH EDUCATION/RISK COMMUNICATION SYSTEMS. THEY ARE TO INFORM MEDICARE BENEFICIARIES OF THE RELATIONSHIP BETWEEN HEALTH HABITS/HEALTH STATUS AND HEALTH OUTCOMES (MORTALITY AND DAYSOF HOSPITALIZATION), AND THE POTENTIAL FOR RISK REDUCTION. THIS PROJECT WILL DEVELOP TWO INTER-RELATED HEALTH EDUCATION/RISK COMMUNICATION SYSTEMS. THEY ARE TO INFORM MEDICAR ...

A NEED EXISTS FOR A RAPID ACTION VALVE WITH A MINIMUM PRESSURE CAPABILITY OF 20,000 PSI AND WITH A MINIMUM FLOW PASSAGE AREA OF 0.05 SQUARE INCH FOR USE IN HIGH PRESSURE OXYGEN TEST SYSTEMS. THE APPROACH IN THIS PROJECT PROVIDES UNIQUE DESIGN FEATURES THAT REDUCE NECESSARY ACTUATION POWER TO EXISTING STATE-OF-THE-ART RAPID ACTION ELECTRICAL SOLENOIDS. THESE SOLENOIDS ARE CAPABLE OF STROKING THE VA ...

N/A

N/A

N/A

A NOVEL PROCESS FOR FIXED-BED ADSORPTION USING ACTIVATED CARBON AND SOLVENT REGENERATION IS PROPOSED FOR INVESTIGATION. THE PROCESS OFFERS EASIER AND LESS COSTLY SOLVENT REGNERATION, REDUCED ADSORBER BED-LENGTH REQUIREMENTS, REDUCED CONCENTRATIONS OF ADSORBED WATER, AND LOWER PROCESS ENERGY REQUIREMENT AND CAPITAL AND OPERATING COSTS. THE PROCESS WILL HAVE APPLICATION TO THE RECOVERY OF SPECIFIC I ...

THE INCREASED RELIANCE OF THE POWER INDUSTRY ON U.S. COAL RESERVES IS THREATENED BY AN OVERALL DECLINE IN THE DEMAND OF POWER, THE HIGH COST OF FINANCING NEW PLANTS, MORE STRINGENT REGULATORY REQUIREMENTS, AND INEFFICIENT ENERGY RECOVERY AND POLLUTION CONTROL. CONVENTIONAL AND ESTABLISHED EMERGING COAL-FIRED POWER GENERATION TECHNOLOGIES DO NOT APPEAR TO OFFER THE DESIGN TECHNOLOGY BREAK-THROUGH N ...

SOLUBLE CD4 IS CONSIDERED TO HAVE A GREAT POTENTIAL IN AIDS THERAPY, INCLUDING TREATMENT AND PREVENTION OF AIDS. IN VITRO STUDIES HAVE ESTIMATED THAT A LARGE EXCESS (1000:1) OFSOLUBLE CD4 IS NEEDED TO ACHIEVE A SIGNIFICANT REDUCTION IN INFECTIOUS PARTICLES. IT IS LIKELY THAT AN EXCESS OF SOLUBLE CD4 IS NEEDED CONSTANTLY OVER PROLONGED PERIODS DURING THERAPY IN AIDS PATIENTS. CONVENTIONAL METHODS O ...

Location 1202 ANN ST MADISON, WI 53713 United States N44CN733001 $35 615.00 2 008 BIOMARKER SCREENING WITH REVOLUTIONARY NEOABS Department of Health and Human Services National Institutes of Health SBIR PHS2009-1 NEOCLONE BIOTECHNOLOGY INTERNATIONAL Phase ...